This is evident in the GLP-1 RA advertisements analyzed in our study, which frequently evoke feelings of hope, transformation, and confidence to persuade potential consumers
Consult your benefits administrator to confirm eligibility for your specific account and plan
Read review Dihexa for ME/CFS (Myalgic Encephalomyelitis) DecodeME GWAS preprint Aug 2025 (8 loci, female-only signal), UK ME/CFS Delivery Plan My Full Reality July 2025, NIH Walitt 2024 deep-phenotyping, UBC Nacul LDN trial, NICE NG206, and the ~250,000 UK ME/CFS population
Ill just add that this is all in type 1 diabetes
Private by design Photo estimates go to a 3rd-party AI only with your explicit consent
Nature Medicine, 2024 How much lower blood sugar (HbA1c, a three-month marker) ran in the higher-dose groups of the Phase 2 diabetes trial